Related references
Note: Only part of the references are listed.Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States
Christopher P. Cannon et al.
AMERICAN HEART JOURNAL (2020)
Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United States
Leah J. McGrath et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)
Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association
Jennifer G. Robinson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Frailty and Comorbidities Among Survivors of Adolescent and Young Adult Cancer: A Cross-Sectional Examination of a Hospital-Based Survivorship Cohort
Andrew B. Smitherman et al.
JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors
Dionne M. Hines et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2018)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of expanding the look-back period to all available data in the assessment of covariates
Sonja S. Nakasian et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Negative Control Outcomes A Tool to Detect Bias in Randomized Trials
Benjamin F. Arnold et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Negative Controls A Tool for Detecting Confounding and Bias in Observational Studies
Marc Lipsitch et al.
EPIDEMIOLOGY (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Use of propensity score technique to account for exposure-related covariates - An example and lesson
John D. Seeger et al.
MEDICAL CARE (2007)
Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect
M. Alan Brookhart et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Evidence of bias in estimates of influenza vaccine effectiveness in seniors
LA Jackson et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
An application of propensity score matching using claims data
JD Seeger et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests
JM Robins et al.
BIOMETRICS (2000)
Share Paper
